US accuses Regeneron of fraudulent price reporting for eye drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/10/2026

1. COO
2. CHWY
3. AVAV
4. SPY
5. ASO
6. NAVN
7. AAPL
8. AEO
9. PLTR
10. CNM

Go back to US accuses Regeneron of fraudulent price reporting for eye drug
Regeneron (NASDAQ: REGN) Delayed: 797.30 -10.35 (1.28%)
Previous Close $807.65    52 Week High $592.36 
Open $794.36    52 Week Low $325.35 
Day High $806.14    P/E 209.27 
Day Low $792.90    EPS $3.81 
Volume 198,111